Bill journey · stage 2 of 5
Under committee review
What it doesSummary passed house amended (Sep 26, 2016)
Dangerous Synthetic Drug Control Act of 2016
(Sec. 2) This bill amends the Controlled Substances Act to add certain synthetic opioids, hallucinogens, and cannabinoids to schedule I. (A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)
What just happenedSep 27, 2016
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Who’s behind it
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
The title of the measure was amended. Agreed to without objection.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 258 - 101 (Roll no. 557). (text: CR H5871-5872)
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 258 - 101 (Roll no. 557).(text: CR H5871-5872)
Considered as unfinished business. (consideration: CR H5893)
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
DEBATE - The House proceeded with forty minutes of debate on H.R. 3537.
Considered under suspension of the rules. (consideration: CR H5871-5874)
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
Placed on the Union Calendar, Calendar No. 615.
Committee on the Judiciary discharged.
Committee on the Judiciary discharged.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-787, Part I.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-787, Part I.
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Committee Consideration and Mark-up Session Held.
Committee Consideration and Mark-up Session Held.
Forwarded by Subcommittee to Full Committee by Voice Vote .
Subcommittee Consideration and Mark-up Session Held.
Subcommittee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Dangerous Synthetic Drug Control Act of 2016
(Sec. 2) This bill amends the Controlled Substances Act to add certain synthetic opioids, hallucinogens, and cannabinoids to schedule I. (A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)
Synthetic Drug Control Act of 2015
This bill amends the Controlled Substances Act (CSA) to modify the definition of "controlled substance analogue" to mean a substance that has a similar (previously, substantially similar) chemical structure and pharmacological effect to a schedule I controlled substance.
The CSA's requirements, prohibitions, and restrictions with respect to schedule I controlled substances apply to the manufacture, importation, distribution, and sale (but not possession) of a controlled substance analogue.
The bill amends the Controlled Substances Analogue Enforcement Act of 1986 to add certain synthetic substances to schedule I of the CSA.